Home / Cancer Care / Determining your risk for pancreatic cancer

Determining your risk for pancreatic cancer

Pancreatic cancer screening
New research suggests pancreatic cancer screening for those at high risk could prove beneficial.

For many years, doctors have recommended screenings for breast, colon and other types of cancer. New research suggests screening for those at high risk for pancreatic cancer also could prove beneficial.

Pancreatic cancer is one of the most deadly types of cancers. According to the American Cancer Society, pancreatic cancer accounts for about 7% of all cancer deaths in the U.S., but only 3% of all cancers in the U.S.

“If someone in your family is diagnosed with pancreatic cancer, it is important to talk to your provider about your personal risks of developing the condition,” said Dr. Jessica Wernberg, surgical oncologist and director of the High Risk Pancreatic Screening Program at Marshfield Clinic Health System.

Who is at increased risk?

Research has discovered several groups of people that are at an increased risk of pancreatic cancer. These groups include:

  • Patients with a family history of pancreatic cancer in two or more relatives from the same side of the family.
  • Patients with at least one relative with pancreatic cancer and one of the following gene mutations:
    • ATM
    • BRCA1 or BRCA2 (Hereditary Breast and Ovarian Cancer Syndrome)
    • MLH1, MLH2, MSH6 or EPCAM (Lynch Syndrome)
    • PALB2
    • TP53 (Li-Fraumeni Syndrome)
  • Patients, regardless of family history, with one of the following gene mutations:
    • STK11 (Puetz-Jeghers syndrome)
    • CDKN2A (Familial Atypical Multiple Mole Melanoma)
  • Patients with a diagnosis of hereditary pancreatitis.

If you are found to be at increased risk for pancreatic cancer, your care team may recommend additional screening to find any signs of cancer earlier and lifestyle modifications that can reduce your chance of developing pancreatic cancer.

Screening for pancreatic cancer

If you are at an increased risk for developing pancreatic cancer, Dr. Wernberg suggests guideline-based screenings for early detection of abnormalities.

These screening tests may involve imaging techniques such as MRI and/or endoscopic ultrasound.

“These tests would be conducted just like other cancer screening tests to ensure we can catch any signs of pancreatic cancer as soon as possible,” Dr. Wernberg said. “While this approach is new, we are excited that it is evolving quickly.”

For more information about high risk pancreatic cancer screening, talk to your provider about available options, or contact the High Risk Pancreatic Cancer Screening program at the Health System by calling 1-800-367-0982.

Concern for eyes leads patient to pancreatic cancer diagnosis

Lois TeStrake, a long-time resident of Marshfield, Wisconsin has a passion for life and helping the people around her. A question of concern from a stranger helped her discover she had pancreatic cancer.

TeStrake was enjoying a normal day as she was working in a local clothing store. After helping one customer, she received a surprising question. “Is there something wrong? Your eyes are looking yellow.” That customer was Dr. Wernberg, surgical oncologist at Marshfield Clinic Health System. This concern prompted TeStrake to call Dr. Wernberg’s office for further testing.

Initially her care team had thought TeStrake had plugged bile ducts that were causing her jaundice, and she was scheduled for surgery. Then they discovered she had stage two pancreatic cancer. Dr. Wernberg and Chady Leon, M.D., hematology-oncology specialist, brought together a multi-disciplinary team of specialists from surgery, gastroenterology, oncology and radiation oncology to discuss her care and created a treatment plan.

Watch how Dr. Wernberg’s concern made a difference for TeStrake.

Related posts

Pancreatic cancer: 3 things to know

BRCA1 and BRCA2 and their effect on cancer

Cancer basics: What you need to know

2 responses to “Determining your risk for pancreatic cancer”

  1. Larry Baumgartner

    The article implies that knowing your gene mutation profile is an important part your risk assessment , yet I wonder how many of us have had any kind of genetic testing and to know that of our relatives even less likely. I don't recall seeing any of these mutations being referenced in my 23 and Me genetic studies. Perhaps another article discussing the how , where, and the cost of genetic health studies is due.

    1. Jacob Zipperer

      Hi Larry,

      Thank you for reading and reaching out. Help understanding genetic tests from companies like 23 and Me is a common concern we hear from patients (the below blog post provides more information on that). If you would like to learn more about genetic testing, you can learn more about our genetic counselors here: https://www.marshfieldclinic.org/specialties/medical-genetics-services

      https://shine365.marshfieldclinic.org/wellness/at-home-genetic-testing/

      Thank you,
      Jake

Leave a Reply

Your email address will not be published. Required fields are marked *